Risedronate reduces the risk of first vertebral fracture in osteoporotic women.

Saved in:
Bibliographic Details
Title: Risedronate reduces the risk of first vertebral fracture in osteoporotic women.
Authors: Heaney RP; Creighton University, Omaha, Nebraska 68131, USA. rheaney@creighton.edu, Zizic TM, Fogelman I, Olszynski WP, Geusens P, Kasibhatla C, Alsayed N, Isaia G, Davie MW, Chesnut CH 3rd
Source: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2002; Vol. 13 (6), pp. 501-5.
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer International Country of Publication: England NLM ID: 9100105 Publication Model: Print Cited Medium: Print ISSN: 0937-941X (Print) Linking ISSN: 0937941X NLM ISO Abbreviation: Osteoporos Int Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0937-941X
DOI:10.1007/s001980200061